Shanghai Pharmaceuticals Holding Co Ltd
Company Profile
Business description
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
Contact
No. 200 Taicang Road
Shanghai Pharmaceutical Building
Shanghai200020
CHNT: +86 2163730908
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
49,608
Stocks News & Analysis
stocks
Why stocks sometimes fall for no obvious reason
stocks
Poor organic growth obscured by acquisition for ASX listed share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,882.60 | 20.50 | -0.23% |
| CAC 40 | 8,173.11 | 85.15 | -1.03% |
| DAX 40 | 25,184.89 | 204.21 | -0.80% |
| Dow JONES (US) | 50,391.21 | 188.49 | -0.37% |
| FTSE 100 | 10,491.39 | 25.13 | 0.24% |
| HKSE | 25,599.45 | 6.58 | -0.03% |
| NASDAQ | 26,602.54 | 258.57 | 0.98% |
| Nikkei 225 | 64,996.09 | 162.10 | -0.25% |
| NZX 50 Index | 13,069.74 | 99.46 | 0.77% |
| S&P 500 | 7,511.88 | 38.41 | 0.51% |
| S&P/ASX 200 | 8,657.80 | 18.80 | -0.22% |
| SSE Composite Index | 4,145.37 | 7.20 | -0.17% |